Status | Study |
Recruiting |
Study Name: A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed Medulloblastoma Condition: Medulloblastoma Date: 2013-06-10 Interventions: Radiation: Craniospinal Irradiation with boost to the primary tumor site |
Recruiting |
Study Name: Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas Condition: Medulloblastoma Date: 2013-05-16 Interventions: Drug: carboplatine carboplatin |
Active, not recruiting |
Study Name: A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Condition: Medulloblastoma Date: 2012-10-11 Interventions: Drug: LDE225 |
Withdrawn |
Study Name: A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma Condition: Medulloblastoma, Childhood Rhabdomyosarcoma Date: 2012-09-28 Interventions: Drug: LY2940680 Capsule admini |
Recruiting |
Study Name: Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway Condition: Histologically Confirmed Medulloblastoma Activation of the Soni Date: 2012-05-15 Interventions: Drug: vismodegib Hedgehog path |
Active, not recruiting |
Study Name: Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults Condition: Medulloblastoma Date: 2012-04-26 Interventions: Drug: maintenance chemotherapy (vincristin, cisplatin and CCNU) |
Terminated |
Study Name: Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma Condition: Neuroblastoma Medulloblastoma Date: 2011-11-28 Interventions: Drug: TPI 287 Subjects will receive six cycles of intravenous (IV) TPI 287 at a dose of 125 mg/m2 on Day |
Recruiting |
Study Name: Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma Condition: Medulloblastoma Date: 2011-05-17 Interventions: Drug: Bevacizumab 10mg/kg, int |
Active, not recruiting |
Study Name: Hyperfractionated Versus Conventionally Fractionated Radiotherapy in Standard Risk Medulloblastoma Condition: Medulloblastoma Date: 2011-05-09 Interventions: Radiation: Standard Fractionation Regimen |
Completed |
Study Name: Vismodegib in Treating Younger Patients With Recurrent or Refractory Medulloblastoma Condition: Recurrent Childhood Medulloblastoma Date: 2010-11-10 Interventions: Other: Laboratory Biomarker Analysis |